U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07753031) titled 'Non-Interventional Study of Ferretab(R) Comp. (Ferrous Fumarate + Folic Acid Prolonged-Release Capsules) Effects in Adult Patients With Iron Deficiency Anemia and Cardiovascular Disease' on Aug. 04.

Brief Summary: The goal of this observational study is to learn how well Ferretab(R) comp. works and how safe it is for adults with iron deficiency anemia and cardiovascular disease who are receiving treatment as part of their usual medical care. The main questions it aims to answer are:

* Does treatment with Ferretab(R) comp. improve anemia?

* Does treatment with Ferretab(R) comp. improve heart-related symptoms, exercise tolerance, and...